Annual Total Liabilities
$21.13 M
-$158.00 K-0.74%
December 1, 2024
Summary
- As of February 21, 2025, KRBP annual total liabilities is $21.13 million, with the most recent change of -$158.00 thousand (-0.74%) on December 1, 2024.
- During the last 3 years, KRBP annual total liabilities has risen by +$17.72 million (+519.74%).
- KRBP annual total liabilities is now -0.74% below its all-time high of $21.29 million, reached on December 31, 2023.
Performance
KRBP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$21.13 M
+$1.60 M+8.19%
December 1, 2024
Summary
- As of February 21, 2025, KRBP quarterly total liabilities is $21.13 million, with the most recent change of +$1.60 million (+8.19%) on December 1, 2024.
- Over the past year, KRBP quarterly total liabilities has increased by +$1.60 million (+8.19%).
- KRBP quarterly total liabilities is now -0.74% below its all-time high of $21.29 million, reached on December 31, 2023.
Performance
KRBP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KRBP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | +8.2% |
| 3 y3 years | +519.7% | +6.0% |
| 5 y5 years | +3036.7% | +6.0% |
KRBP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +519.7% | -0.7% | +519.7% |
| 5 y | 5-year | -0.7% | +3036.7% | -0.7% | +3036.7% |
| alltime | all time | -0.7% | +3360.3% | -0.7% | +3036.7% |
Kiromic BioPharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $21.13 M(-0.7%) | $21.13 M(+8.2%) |
| Sep 2024 | - | $19.53 M(+10.8%) |
| Jun 2024 | - | $17.63 M(-11.1%) |
| Mar 2024 | - | $19.84 M(-6.8%) |
| Dec 2023 | $21.29 M(+20.0%) | $21.29 M(+13.7%) |
| Sep 2023 | - | $18.72 M(-6.1%) |
| Jun 2023 | - | $19.93 M(-6.2%) |
| Mar 2023 | - | $21.25 M(+19.8%) |
| Dec 2022 | $17.74 M | $17.74 M(+39.3%) |
| Sep 2022 | - | $12.74 M(+64.6%) |
| Jun 2022 | - | $7.74 M(+32.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.86 M(+71.8%) |
| Dec 2021 | $3.41 M(+132.3%) | $3.41 M(+136.0%) |
| Sep 2021 | - | $1.44 M(-7.8%) |
| Jun 2021 | - | $1.57 M(-7.8%) |
| Mar 2021 | - | $1.70 M(+15.8%) |
| Dec 2020 | $1.47 M(+117.8%) | $1.47 M(-34.8%) |
| Sep 2020 | - | $2.25 M(+26.0%) |
| Jun 2020 | - | $1.79 M(+101.5%) |
| Mar 2020 | - | $886.70 K(+31.6%) |
| Dec 2019 | $673.70 K(+10.3%) | $673.70 K |
| Dec 2018 | $610.70 K | - |
FAQ
- What is Kiromic BioPharma annual total liabilities?
- What is the all time high annual total liabilities for Kiromic BioPharma?
- What is Kiromic BioPharma annual total liabilities year-on-year change?
- What is Kiromic BioPharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly total liabilities year-on-year change?
What is Kiromic BioPharma annual total liabilities?
The current annual total liabilities of KRBP is $21.13 M
What is the all time high annual total liabilities for Kiromic BioPharma?
Kiromic BioPharma all-time high annual total liabilities is $21.29 M
What is Kiromic BioPharma annual total liabilities year-on-year change?
Over the past year, KRBP annual total liabilities has changed by -$158.00 K (-0.74%)
What is Kiromic BioPharma quarterly total liabilities?
The current quarterly total liabilities of KRBP is $21.13 M
What is the all time high quarterly total liabilities for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly total liabilities is $21.29 M
What is Kiromic BioPharma quarterly total liabilities year-on-year change?
Over the past year, KRBP quarterly total liabilities has changed by +$1.60 M (+8.19%)